Preliminary reports suggest conolidine may inhibit certain ion channels, decreasing neuronal excitability and restricting agony signals. This mechanism is particularly appropriate in neuropathic discomfort, where abnormal signaling will cause persistent irritation. Moreover, conolidine appears to influence G protein-coupled receptor (GPCR) pathways